NGM Biopharmaceuticals, Inc. (NGM) Tops Q4 EPS by 6c

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) reported Q4 EPS of ($0.33), $0.06 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on NGM Biopharmaceuticals, Inc. (NGM) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c